Back to Search
Start Over
P125 Neoadjuvant pembrolizumab + chemotherapy vs placebo + chemotherapy followed by adjuvant pembrolizumab vs placebo for early TNBC: surgical outcomes from the phase 3 KEYNOTE-522 study
- Source :
- Breast, Vol 68, Iss , Pp S63-S64 (2023)
- Publication Year :
- 2023
- Publisher :
- Elsevier, 2023.
- Subjects :
- Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Subjects
Details
- Language :
- English
- ISSN :
- 15323080, 09609776, and 74922939
- Volume :
- 68
- Issue :
- S63-S64
- Database :
- Directory of Open Access Journals
- Journal :
- Breast
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.f7da6e644f749229398d191714cb09f
- Document Type :
- article
- Full Text :
- https://doi.org/10.1016/S0960-9776(23)00242-4